Telecomunicazioni
CELLINK launches the BIO MDX Series , a scaled-up revolution in biomedical manufacturing
" ," says Héctor Martínez, CELLINK CTO.
" ," says Artur Aira , CELLINK Bioprinting Business Area Manager.
Phone (US): +1 (650) 515 5566
Email: eg@cellink.com
Phone (US): +1 (857) 332 2138
Email: gd@cellink.com
About CELLINK
Founded in 2016, CELLINK is the leading bioconvergence company in the world that provides technologies, products and services to create, understand and master biology. With a focus on the application areas of bioprinting, multiomics, cell line development, and diagnostics, the company develops and markets innovative technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical and cosmetic industries. CELLINK's products are trusted by more than 1,800 laboratories, including ones at all the top 20 pharmaceutical companies, are being used in more than 65 countries, and have been cited in more than 1,600 publications. CELLINK is creating the future of medicine. CELLINK is listed on the Nasdaq the Stockholm under CLNK B. www.cellink.com
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/cellink-ab/r/cellink-launches-the-bio-mdx-series---a-scaled-up-revolution-in-biomedical-manufacturing,c3306652
The following files are available for download:
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/cellink-ab/r/cellink-launches-the-bio-mdx-series---a-scaled-up-revolution-in-biomedical-manufacturing,c3306652
The following files are available for download: